Bupivacaine and botulinum toxin to treat comitant strabismus

PURPOSE: To evaluate the change in ocular motility and muscle thickness measured with ultrasonography after intramuscular injection of bupivacaine and botulinum toxin A. METHODS: Eight patients (five female) were enrolled to measure ocular motility prior and 1, 7, 30 and 180 days after one injection...

Full description

Bibliographic Details
Main Authors: Luisa Moreira Hopker, Priscila Fernandes Zaupa, Acácio Alves de Souza Lima Filho, Monica Fialho Cronemberger, Marcia Keiko Uyeno Tabuse, Célia Regina Nakanami, Norma Allemann, Tomás Scalamandré Mendonça
Format: Article
Language:English
Published: Conselho Brasileiro de Oftalmologia 2012-04-01
Series:Arquivos Brasileiros de Oftalmologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492012000200008&lng=en&tlng=en
id doaj-1eebc9eb45d44346b3df0ace8a7b55ac
record_format Article
spelling doaj-1eebc9eb45d44346b3df0ace8a7b55ac2020-11-24T23:45:22ZengConselho Brasileiro de OftalmologiaArquivos Brasileiros de Oftalmologia1678-29252012-04-0175211111510.1590/S0004-27492012000200008S0004-27492012000200008Bupivacaine and botulinum toxin to treat comitant strabismusLuisa Moreira Hopker0Priscila Fernandes Zaupa1Acácio Alves de Souza Lima Filho2Monica Fialho Cronemberger3Marcia Keiko Uyeno Tabuse4Célia Regina Nakanami5Norma Allemann6Tomás Scalamandré Mendonça7Universidade Federal de São PauloUniversidade Federal de São PauloUniversidade Federal de São PauloUniversidade Federal de São PauloUniversidade Federal de São PauloUniversidade Federal de São PauloUniversidade Federal de São PauloUniversidade Federal de São PauloPURPOSE: To evaluate the change in ocular motility and muscle thickness measured with ultrasonography after intramuscular injection of bupivacaine and botulinum toxin A. METHODS: Eight patients (five female) were enrolled to measure ocular motility prior and 1, 7, 30 and 180 days after one injection of 2 ml of 1.5% bupivacaine and 2.5 U of botulinum toxin A in agonist and antagonist muscles, respectively, of eight amblyopic eyes. Muscle thickness was measured prior and on days 1, 7 and 30 after injection using 10-MHz ultrasonography (eyelid technique). RESULTS: Mean change in alignment was 10 prism diopters after 180 days (n=6). An average increase of 1.01 mm in muscle thickness was observed after 30 days of bupivacaine injection and 0.28 mm increase was observed after botulinum toxin A injection, as measured by ultrasonography. Lateral rectus muscles injected with bupivacaine had a mean increase of 1.5 mm in muscle thickness. CONCLUSION: In this study, a change in ocular motility was observed after 180 days of intramuscular injection of bupivacaine and botulinum toxin in horizontal extraocular muscles. Overall, there was an increase of muscle thickness in both botulinum toxinum A and bupivacaine injected muscles after 30 days of injection when measured by ultrasonography. This change was more pronounced on lateral rectus muscles after bupivacaine injection.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492012000200008&lng=en&tlng=enMúsculos oculomotoresEstrabismoEstrabismoEsotropiaToxinas botulínicas tipo AToxinas botulínicas tipo ABupivacaínaBupivacaínaInjeções intramuscularesUltrassonografia
collection DOAJ
language English
format Article
sources DOAJ
author Luisa Moreira Hopker
Priscila Fernandes Zaupa
Acácio Alves de Souza Lima Filho
Monica Fialho Cronemberger
Marcia Keiko Uyeno Tabuse
Célia Regina Nakanami
Norma Allemann
Tomás Scalamandré Mendonça
spellingShingle Luisa Moreira Hopker
Priscila Fernandes Zaupa
Acácio Alves de Souza Lima Filho
Monica Fialho Cronemberger
Marcia Keiko Uyeno Tabuse
Célia Regina Nakanami
Norma Allemann
Tomás Scalamandré Mendonça
Bupivacaine and botulinum toxin to treat comitant strabismus
Arquivos Brasileiros de Oftalmologia
Músculos oculomotores
Estrabismo
Estrabismo
Esotropia
Toxinas botulínicas tipo A
Toxinas botulínicas tipo A
Bupivacaína
Bupivacaína
Injeções intramusculares
Ultrassonografia
author_facet Luisa Moreira Hopker
Priscila Fernandes Zaupa
Acácio Alves de Souza Lima Filho
Monica Fialho Cronemberger
Marcia Keiko Uyeno Tabuse
Célia Regina Nakanami
Norma Allemann
Tomás Scalamandré Mendonça
author_sort Luisa Moreira Hopker
title Bupivacaine and botulinum toxin to treat comitant strabismus
title_short Bupivacaine and botulinum toxin to treat comitant strabismus
title_full Bupivacaine and botulinum toxin to treat comitant strabismus
title_fullStr Bupivacaine and botulinum toxin to treat comitant strabismus
title_full_unstemmed Bupivacaine and botulinum toxin to treat comitant strabismus
title_sort bupivacaine and botulinum toxin to treat comitant strabismus
publisher Conselho Brasileiro de Oftalmologia
series Arquivos Brasileiros de Oftalmologia
issn 1678-2925
publishDate 2012-04-01
description PURPOSE: To evaluate the change in ocular motility and muscle thickness measured with ultrasonography after intramuscular injection of bupivacaine and botulinum toxin A. METHODS: Eight patients (five female) were enrolled to measure ocular motility prior and 1, 7, 30 and 180 days after one injection of 2 ml of 1.5% bupivacaine and 2.5 U of botulinum toxin A in agonist and antagonist muscles, respectively, of eight amblyopic eyes. Muscle thickness was measured prior and on days 1, 7 and 30 after injection using 10-MHz ultrasonography (eyelid technique). RESULTS: Mean change in alignment was 10 prism diopters after 180 days (n=6). An average increase of 1.01 mm in muscle thickness was observed after 30 days of bupivacaine injection and 0.28 mm increase was observed after botulinum toxin A injection, as measured by ultrasonography. Lateral rectus muscles injected with bupivacaine had a mean increase of 1.5 mm in muscle thickness. CONCLUSION: In this study, a change in ocular motility was observed after 180 days of intramuscular injection of bupivacaine and botulinum toxin in horizontal extraocular muscles. Overall, there was an increase of muscle thickness in both botulinum toxinum A and bupivacaine injected muscles after 30 days of injection when measured by ultrasonography. This change was more pronounced on lateral rectus muscles after bupivacaine injection.
topic Músculos oculomotores
Estrabismo
Estrabismo
Esotropia
Toxinas botulínicas tipo A
Toxinas botulínicas tipo A
Bupivacaína
Bupivacaína
Injeções intramusculares
Ultrassonografia
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492012000200008&lng=en&tlng=en
work_keys_str_mv AT luisamoreirahopker bupivacaineandbotulinumtoxintotreatcomitantstrabismus
AT priscilafernandeszaupa bupivacaineandbotulinumtoxintotreatcomitantstrabismus
AT acacioalvesdesouzalimafilho bupivacaineandbotulinumtoxintotreatcomitantstrabismus
AT monicafialhocronemberger bupivacaineandbotulinumtoxintotreatcomitantstrabismus
AT marciakeikouyenotabuse bupivacaineandbotulinumtoxintotreatcomitantstrabismus
AT celiareginanakanami bupivacaineandbotulinumtoxintotreatcomitantstrabismus
AT normaallemann bupivacaineandbotulinumtoxintotreatcomitantstrabismus
AT tomasscalamandremendonca bupivacaineandbotulinumtoxintotreatcomitantstrabismus
_version_ 1725495905458585600